chevron_leftBack
As of 24 April 2025, Medacta Group S.A. has a market cap of $3.11B USD, ranking #4096 globally and #80 in Switzerland. It ranks #350 in the Healthcare sector, and #40 in the Medical Devices industry.
Key Stats
Market Cap
$3.11BUSD
2.57B CHF
Enterprise Value
$3.35BUSD
2.76B CHF
Revenue (TTM)
$670.86MUSD
554.07M CHF
EBITDA (TTM)
$161.52MUSD
133.4M CHF
Net Income (TTM)
$82.79MUSD
68.38M CHF
EBITDA Margin
24%
Profit Margin
12%
PE Ratio
37.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Francesco Siccardi
open_in_new
Employees
1,907
Founded
1958
Website
medacta.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.4% | 6.6% | 1.6% | 16% | 7.2% | 17% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MOVE
Medacta Group SA Ordinary Shares
ISIN: CH0468525222
Shares Out.:
Shares Outstanding:
19.919M1
Shares Float:
6.085M2
|
127.00 CHF | |
|
0A05
Medacta Group SA Ordinary Shares
ISIN: CH0468525222
|
123.74 CHF |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Medacta Group S.A.
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
Country |
|---|---|---|
Sonova Holding AG
SIX: SOON
|
$17.44B
461%
14.4B CHF
|
|
Medartis Holding AG
SIX: MED
|
$1.14B
-63%
942.1M CHF
|
|
Kuros Biosciences AG
SIX: KURN
|
$1.01B
-68%
832.09M CHF
|
